Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer's-like pathology and symptoms through multiple targeting actions in aged T2D rats
Adel A. Gomaa, Hanan S.M. Farghaly, Asmaa M. Ahmed, Fahmy K. Hemida
Topics & Concepts
NeuroprotectionMorris water navigation taskMedicineInternal medicineEndocrinologyHippocampusNeurodegenerationAlzheimer's diseaseDonepezilPharmacologyDementiaDiseasePhosphodiesterase function and regulationAntioxidants, Aging, Portulaca oleraceaAlzheimer's disease research and treatments